SNX9 and oculocerebrorenal syndrome: Not surprisingly, the deregulation of SNX9 expression contributes to many human diseases, including Lowe syndrome (Nandez et al., 2014), Chlamydia-induced infection (Hansch et al., 2020), chronic inflammation (Ish-Shalom et al., 2016), and cancer (Bendris et al., 2016a, b).